Candel Therapeutics, Inc.CADLNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-38.31M
↓ 60% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-23.92M
Historical baseline
PeriodValueYoY Change
2025$-38.31M-41.8%
2024$-27.02M+21.1%
2023$-34.24M-9.0%
2022$-31.42M-41.4%
2021$-22.22M-144.9%
2020$-9.07M-75.2%
2019$-5.18M-